TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 1 | 1 | 3 | 2 | 12 | 6 | -7 | -2 | 1 | 2 |
| P | %wins | 67 | 100 | 100 | 0 | 33 | 33 | 56 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
4/1/24 16:01 | 3/28/24 | GANX | Gain Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Riley Jeffrey Scott | MD | D | P | 116 | 3.86 | 0 | 30 | New | 30 | D | |||||||||||||||
1/7/13 16:08 | 1/7/13 | SYN | Synthetic Biologics, Inc. | NV | Health | Drug | Pharmaceutical Preparations | Riley Jeffrey Scott | MI | DO | CEO,P | P | 1 | 0.1747 | 0 | 3 | 39 | 10 | D | 26 | 34 | -10 | -19 | -12 | -2 | -8 | -3 | 6 | 10 | 2 | -11 | -4 | 9 |
1/4/13 16:30 | 1/3/13 | SYN | Synthetic Biologics, Inc. | NV | Health | Drug | Pharmaceutical Preparations | Riley Jeffrey Scott | MI | DO | CEO,P | P | 3 | 1.71 | 0 | 2 | 36 | 8 | D | 37 | 36 | -11 | -18 | -11 | 5 | -8 | 5 | 2 | 12 | 7 | -6 | 0 | -1 |
1/3/13 16:47 | 1/2/13 | SYN | Synthetic Biologics, Inc. | NV | Health | Drug | Pharmaceutical Preparations | Riley Jeffrey Scott | MI | DO | CEO,P | P.m | 10 | 1.76 | 0 | 6 | New | 6 | D | 56 | 41 | -10 | -14 | -10 | 11 | 11 | 6 | -1 | 15 | 10 | -5 | -2 | -6 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |